It has been estimated that in 2002 the size of the traditional Chinese medicine (TCM) market in China will be about $ 5 billion. Decades of Chinese regulatory reforms, liberalization of Chinese pharmaceutical industry, changes in the Chinese way of life and demographics, and the Chinese pharmaceutical research and development facilities were factors behind the huge market potential TCM in China. Multinational corporations that want to enter this market, you may have to deal with the lack of protection of intellectual property, corruption in health insurance reimbursement, complex regulatory procedures, and least price, bidding and distribution practices. "Hide
by Ali Farhoomand, Scarlet Chan, Shirley Chan 21 pages. Publication Date: March 18, 2005. Prod. #: HKU391-PDF-ENG
Related Case Solutions & Analyses:
From Blueprint to Genetic Code: The Merits of an Evolutionary Approach to Design
Uncommon Sense: How to Turn Distinctive Beliefs into Action
The Dow Acquisition of Rohm and Haas (B)
The StarNight Hotel Construction Bid: Real Time Competition on Schedule Scope and Cost
Valuing Assets in Financial Markets
Restructuring of Chinas Automobile Industry after Chinas Entry into WTO
Arctic Timber AB: Engineered Woods Division (B)
Aristotle Onassis and the Greek Shipping Industry
Leading Public Professional Service Organizations
Hewlett-Packard: Singapore (D)
